Guitar Party cards from American Greetings strike a new chord
The newest invention from American Greetings is said to be a great way to amplify birthday wishes and turn the big day into a chart-topping experience with new Guitar Party cards.
Supplier News
Dermira gets FDA approval for Qbrexza cloth
Dermira announced that the U.S. Food and Drug Administration (FDA) has approved Qbrexza (glycopyrronium) cloth, an anticholinergic indicated for the topical treatment of primary axillary hyperhidrosis in adult and pediatric patients 9 years of age and older.
Novartis seeks approval to spinoff Alcon eye care biz
Novartis today announced its intention to spinoff Alcon, its eye care division, into a separately-traded standalone company. The planned spinoff would enable Novartis and Alcon to focus fully on their respective growth strategies.
gel-e expands its OTC label
gel-e Inc., announces the 510(k) clearance of gel-e FLEX by the U.S. Food and Drug Administration (FDA) for the over-the-counter (O-T-C) use of its first flowable hemostat.
Playtex Simply Gentle Glide relaunch provides a little “extra”
Based on an insight that today’s consumers experience an influx of “extra” – from numerous ads, product offerings and even personalities – so much that society has invented internet slang: #Extra. To poke fun at these overly extra moments in a spoof-like-spirit (i.e.
Sensormatic anti-theft label fits health, beauty retail model
Tyco Retail Solutions has introduced its new Sensormatic Health, Beauty and Cosmetic (HBC) Label, providing an anti-theft solution for beauty items difficult to protect or not currently protected due to size or shape constraints.
Lupin and Mylan team up to commercialize Enbrel
Pharma major Lupin and Mylan announced that the two companies will partner to commercialize a biosimilar to Enbrel (etanercept).
Avella to distribute Braftovi and Mektovi
Avella has announced that it will distribute Braftovi (encorafenib and Mektovi (binimetinib), a combination therapy recently FDA approved for patients for the treatment of patients with unresectable or metastatic melanoma.
Starco Brands unveils Honu sunscreen with patented spray wand
In order to apply sunscreen to hard to reach areas such as the back, neck, shoulders, sides, hips, legs and feet, Starco Brands introduces Honu, the first and only sunscreen with a patented spray wand.
Aurobindo launches atazanavir capsules
Aurobindo Pharma has launched atazanavir capsules 100 mg, 150 mg, 200 mg and 300 mg upon receiving final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application.
Soleo Health selected by Genentech to provide two limited distribution drugs
Soleo Health, an innovative leader in specialty infusion services, announced the company has been selected by Genentech (member of the Roche Group), a world-leading biotechnology company with multiple products on the market and a strong development pipeline, to dispense two limited distribution drug
Kimberly-Clark reports progress to sustainability 2022 goals
Kimberly-Clark Corp. has reported its progress toward achieving its Sustainability 2022 strategy to create social, environmental and business value.
HeadBlade names Tom Wainman as new brand spokesperson
HeadBlade, a leader in HeadCare and developers of the ultimate head shaving razor, the HeadBlade MOTO, announced Tom Wainman, formerly a pitchman for Hair Club for Men, as its new spokesperson.
AcneFree and AARS team to help new generation of acne sufferers
AcneFree announces its support of the American Acne and Rosacea Society (AARS), a non-profit organization, as a part of its commitment to better educate the 21 million teenagers in the U.S. – approximately 80% of all teens – who suffer from acne and occasional breakouts.
Upsher-Smith featuring Platinum Pass at AHS meeting
Upsher-Smith Laboratories (Upsher-Smith) announced that it will be featuring Platinum Pass, the latest addition to the Access Pathways Program for Qudexy XR (topiramate) extended-release capsules at the 60th Annual Scientific Meeting of the American Headache Society (AHS), June 28 to July 1, in
FDA grants priority review to single-dose flu drug
Genentech announced that the U.S. Food and Drug Administration (FDA) has accepted a New Drug Application (NDA) and granted Priority Review for baloxavir marboxil as a single-dose, oral treatment for acute, uncomplicated influenza in people 12 years and older.